Google to charge Android partners up to $40 per device for apps: source
(This Oct. 19 story has been refiled to fix wording in fourth paragraph) A 3D printed Android mascot Bugdroid is seen in front of a Google logo in this illustration…
Danske shares slide as U.S. criminal inquiry spooks investors
COPENHAGEN (Reuters) – Danske Bank’s (DANSKE.CO) deepening money laundering scandal dragged its shares to a four-year low on Friday as Denmark’s biggest bank sought to calm investors over the impact…
EMA committee recommends restrictions on fluoroquinolone, quinolone antibiotics
(Reuters) – The European Medicines Agency’s risk assessment committee has recommended restrictions on the use of broad-spectrum antibiotics fluoroquinolone and quinolone following a review of side effects, the EMA said…
Under Armour cuts 400 more jobs in turnaround push
(Reuters) – Under Armour Inc (UA.N) (UAA.N) said on Thursday it was cutting about 400 jobs, or 3 percent of its workforce, as part of the sportswear maker’s efforts to…
U.S. regulator approves Teva migraine drug, shares rise
(Reuters) – Shares of Israeli drugmaker Teva Pharmaceutical Industries rose over 5 percent in after-hours trading on Friday after the U.S. Food and Drug Administration (FDA) approved the company’s new…
Unilever single holding company shares to start trading in December
LONDON (Reuters) – Consumer goods giant Unilever (ULVR.L) (UNc.AS) said simplifying its parent company structure from two UK and Dutch legal entities into a single holding company would conclude in…
Bayer cuts forecasts on Monsanto delay as lawsuits pile up
FRANKFURT (Reuters) – Bayer cut its earnings forecast on Wednesday due to delays to its $63 billion takeover of Monsanto, and said sales of its consumer care products fell, hitting…
Wall Street extends rally, tech leads S&P, Nasdaq to record highs
(Reuters) – Wall Street extended its rally on Wednesday, with the S&P 500 and the Nasdaq hitting record highs for the fourth straight session as technology companies pushed indexes higher…
Bayer, J&J’s heart drug Xarelto fails trial to widen use
FRANKFURT (Reuters) – Bayer and Johnson & Johnson’s campaign to widen the market for its heart drug Xarelto hit a snag on Sunday when a study for a potential new…
Siemens denies report it may cut 20,000 jobs
MUNICH/BERLIN (Reuters) – German engineering giant Siemens (SIEGn.DE) said a report by monthly Manager Magazin that it could cut 20,000 jobs as part of its Vision 2020+ strategy was “completely…